Pfizer Ponders A Move
A few months ago, pharma giant Pfizer (PFE) got a boost when Sanford Bernstein analyst Tim Anderson (and a few other street colleagues) mentioned that company management was open to spinning off or...
View ArticlePfizer Slowly Making Progress On Animal Health Divestiture
It looks like Pfizer (PFE) is moving ahead with its plans to divest its animal health unit. The latest sign is a recent restructuring of its Indian subsidiary’s animal health unit which was folded into...
View ArticlePfizer CEO Dishes Divestiture Details To Reuters
It has been a long time since Pfizer (PFE) initiated a strategic review of its business units and in the meantime, there has been much speculation regarding which units the company would ultimately...
View ArticlePfizer To IPO Zoetis, Animal Health Division, Spin May Follow
There are many hundreds of thousands of words in the English language, and zoetic is not one of the more common. The word, meaning “of or relating to life”, is the inspiration for Zoetis, the new name...
View ArticleGlaxo Has No Current Plans To Spin Off Viiv, But Does Not Rule It Out
Whenever a corporate executive has to publicly state that they will not be spinning something off, it’s generally only a matter of time. This is likely the case with GlaxoSmithKline(GSK) and its...
View ArticleGrab Your Pets – Pfizer’s Zoetis IPO Set For Friday
Pfizer (PFE) generated a lot of buzz last year when it announced it was considering strategic options for several of its units. Its nutrition business has since been sold to Nestle for over $11b in...
View ArticlePfizer May Be Thinking Spinoff…In 2016
Spinoff talk has surrounded Pfizer (PFE) for some time now following a business unit review a couple of years ago. That ultimately led to the sale of its nutritional unit and the successful IPO of ~20%...
View ArticlePfizer To Uncage Zoetis Stake Via Exchange Offer
Updated 06/04/13 16:43 That didn’t take too long to decide. During its latest conference call, Pfizer (PFE) indicated it was still mulling its options for how to deal with its remaining ~80% stake in...
View ArticleZoetis, Newly Spun Off From Pfizer, To Join S&P 500
As we have written about previously, Pfizer(PFE), after conducting an IPO of 20% of Zoetis(ZTS) in January, has launched an exchange offer whereby shareholders may elect to exchange their Pfizer shares...
View ArticleZoetis Chief Alaix Talks Spinoff, Animal Health Business With WSJ
The WSJ publishes a weekly column titled ‘Boss Talk’ where it picks the brain of CEOs and other top brass from big companies. A few weeks ago the paper spoke with Mike Petters, CEO of Huntington...
View ArticleEnergizer Holdings Keeps Going And Going, To Cut Loose Wilkinson Sword And...
“The wind goes toward the south, and turns about to the north; it turns about continually in its spin, and the wind returns again to its spin.”(Ecclesiastes 1:6) Some companies are such inveterate...
View ArticleCleaning Up The Upcoming Spinoff Table: Autogrill & World Duty Free Group,...
Companies constantly change their plans and just because a spinoff gets announced doesn’t mean it actually gets done. It’s (unfortunately) quite common for plans to get scrapped or altered in some way...
View ArticleThe Spinoff Tease – Glaxo Scraps Plans For ViiV IPO
We have written about British pharma giant GlaxoSmithKline (GSK) a number of times over the past few years, but so far, none of the rumored spinoffs have ever come to fruition. It seems that will...
View ArticleSummer Of Spin: Forbes’ Antoine Gara Likes PayPal and Baxalta
Amidst this great Summer Of Spin, what are the best prospects? According to Forbes’ Antoine Gara, who has also noted the flurry of spinoffs: PayPal and Baxalta(BXLT). About PayPal: PayPal is a leader...
View ArticleUncertainty To Remain As IRS Not Issuing Broad Guidance For Spinoffs Just Yet
Those hoping for the IRS to provide clear guidance on spinoff related tax issues can keep holding their breath because it’s not coming anytime soon, at least according to Robert Wellen, associate chief...
View ArticleTake An Advil? Pfizer Looking At Options For Consumer Health Business
Way back in 2013, Pfizer (PFE) CEO Ian Read plotted a future course that could have included a spinoff several years down the line. Since then there have been constant rumors and speculations about...
View ArticleSpinoff Odds and Ends: Pfizer’s Consumer Business, La Quinta Award Winning Idea
Grab your cup of coffee and kick off the week with some Odds and Ends: Late last year, Pfizer (PFE) announced it was considering its ‘options’ for its consumer health division. The early buzz was all...
View ArticlePfizer Ponders A Move
A few months ago, pharma giant Pfizer (PFE) got a boost when Sanford Bernstein analyst Tim Anderson (and a few other street colleagues) mentioned that company management was open to spinning off or...
View ArticlePfizer Slowly Making Progress On Animal Health Divestiture
It looks like Pfizer (PFE) is moving ahead with its plans to divest its animal health unit. The latest sign is a recent restructuring of its Indian subsidiary’s animal health unit which was folded into...
View ArticlePfizer CEO Dishes Divestiture Details To Reuters
It has been a long time since Pfizer (PFE) initiated a strategic review of its business units and in the meantime, there has been much speculation regarding which units the company would ultimately...
View Article
